Position in PFE
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$112,357
-$15,659 QoQ
Shares Held
4,666
+2.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#2,525
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Financial Management Professionals, Inc. holds $5,803,019 across 15 Drug Manufacturers - General names. PFE ranks #7 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
6,071 | $1,527,706 | |
| 2 | LLY |
ELI LILLY & Co
|
933 | $1,119,068 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
7,239 | $914,575 | |
| 4 | JNJ |
Johnson & Johnson
|
3,299 | $837,847 | |
| 5 | AMGN |
Amgen Inc
|
1,624 | $588,082 | |
| 6 | MRK |
Merck & Co., Inc.
|
3,783 | $486,115 | |
| 7 | PFE |
Pfizer Inc
This page
|
4,666 | $112,357 | |
| 8 | NVS |
Novartis AG
|
562 | $88,076 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $112,357 | 4,666 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $128,016 | 4,559 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $91,208 | 3,663 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $91,065 | 3,574 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $89,348 | 3,686 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $107,517 | 4,243 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $102,618 | 3,868 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $105,949 | 3,661 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $576,388 | 20,600 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $529,719 | 19,089 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $491,992 | 17,089 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $465,905 | 14,046 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $596,820 | 16,271 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $610,612 | 14,966 | Shares | Sole | 2023-04-13 | |
| 2022-12-31 | $610,524 | 11,915 | Shares | Sole | 2023-01-11 | |
| 2022-09-30 | $414,188 | 9,465 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $529,438 | 10,098 | Shares | Sole | 2022-07-12 | |
| 2022-03-31 | $496,060 | 9,582 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $529,324 | 8,964 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $383,090 | 8,907 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $347,545 | 8,875 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $314,440 | 8,679 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $310,381 | 8,432 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $304,316 | 8,292 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $265,720 | 8,126 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $192,706 | 5,904 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||